共 22 条
[1]
Louis DN(2016)The 2016 World Health Organization classification of tumors of the central nervous system: a summary Acta Neuropathol 131 803-820
[2]
Perry A(2016)Pharmacotherapies for the treatment of glioblastoma – current evidence and perspectives Expert Opin Pharmacother 17 1259-1270
[3]
Reifenberger G(2016)PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma Oncotarget 374 1344-1355
[4]
Seystahl K(2016)Radiation plus procarbazine, CCNU, and vincristine in low-grade glioma N Engl J Med 32 783-790
[5]
Gramatzki D(2014)Benefit from procarbazine, lomus-tine, and vincristine in oligodendroglial tumors is associated with mutation of IDH J Clin Oncol 31 344-350
[6]
Roth P(2013)Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951 J Clin Oncol 74 867-872
[7]
Weller M(2015)BRAF fusion analysis in pilocytic astrocytomas: KIAA1549-BRAF 15-9 fusions are more frequent in the midline than within the cerebellum J Neuropathol Exp Neurol undefined undefined-undefined
[8]
Li X(undefined)undefined undefined undefined undefined-undefined
[9]
Wu C(undefined)undefined undefined undefined undefined-undefined
[10]
Chen N(undefined)undefined undefined undefined undefined-undefined